Aprea director granted RSUs and stock options
Aprea Therapeutics director Bernd R. Seizinger reported equity awards that increase his stake in the company.
Rhea-AI Filing Summary
Aprea Therapeutics director Bernd R. Seizinger reported equity awards that increase his stake in the company. He received 3,135 restricted stock units granted on June 16, 2026, which are scheduled to vest and settle in common stock on June 16, 2027, as long as he continues serving on the board. He was also granted stock options for 12,555 shares of common stock at an exercise price of $0.7293 per share, vesting in full on June 16, 2027 and expiring on June 16, 2036. After these grants, he directly holds 48,910 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,690 shares
Grant/Award
2 txns
Insider
Seizinger Bernd R.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 12,555 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 3,135 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 12,555 contracts (Direct);
Common Stock — 48,910 shares (Direct)
Footnotes (2)
- F1. These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- F2. The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Key Figures
RSUs granted: 3,135 units
Options granted: 12,555 options
Option exercise price: $0.7293 per share
+3 more
6 metrics
RSUs granted
3,135 units
Restricted stock units granted June 16, 2026
Options granted
12,555 options
Stock options granted June 16, 2026
Option exercise price
$0.7293 per share
Stock options on common stock
Shares held after
48,910 shares
Common stock directly owned after grants
Vesting date
June 16, 2027
RSUs and options vesting date
Option expiration
June 16, 2036
Expiration date of stock options
Key Terms
restricted stock units, Stock Options (Right to Buy), vest, expiration date
4 terms
restricted stock units financial
"These shares represent restricted stock units which were granted on June 16, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Options (Right to Buy) financial
"Stock Options (Right to Buy) with an exercise price of $0.7293 per share"
vest financial
"which will vest and be settled in common stock on June 16, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"The option vests in full on June 16, 2027 and has an expiration date of June 16, 2036"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Aprea Therapeutics (APRE) director Bernd Seizinger report on this Form 4?
He reported receiving new equity awards. These include restricted stock units and stock options granted as part of his director compensation at Aprea Therapeutics, increasing his direct common stock holdings.
How many restricted stock units did Bernd Seizinger receive from Aprea Therapeutics (APRE)?
He received 3,135 restricted stock units. These RSUs were granted on June 16, 2026 and will vest and settle in common stock on June 16, 2027, subject to his continued service on the board.
What stock options were granted to Bernd Seizinger by Aprea Therapeutics (APRE)?
He was granted options covering 12,555 shares of common stock. The options have a $0.7293 per share exercise price, vest in full on June 16, 2027, and carry an expiration date of June 16, 2036.
When do Bernd Seizinger’s Aprea Therapeutics (APRE) RSUs and options vest?
Both awards are scheduled to vest on June 16, 2027. The 3,135 restricted stock units will settle in common stock, and the 12,555 stock options will become fully exercisable on that same vesting date.
What conditions apply to Bernd Seizinger’s Aprea Therapeutics (APRE) equity awards?
Both the RSUs and options require continued board service through June 16, 2027. The filing notes vesting is subject to his continued service and mentions possible acceleration under certain conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
